PTGS2 and breast carcinoma: These observations expand on a novel role that we recently described for α3β1 in controlling post-transcriptional mRNA processing in breast cancer cells, where we showed that RNAi-mediated suppression of α3 promotes alternative splicing of the cyclooxygenase-2 (COX-2) mRNA that targets it for nonsense-mediated decay [48].